BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
NTES-S
09999
JD-SW
09618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -46.21%17.4M | ---- | 291.76%32.34M | ---- | -75.00%8.26M | ---- | 75.31%33.02M | ---- | 556.99%18.84M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -1,495.45%-2.11M | ---- | -193.33%-132K | ---- | 40.00%-45K | ---- | 65.60%-75K | ---- | -172.50%-218K |
Impairment and provisions: | ---- | 12.39%35M | ---- | 216.04%31.14M | ---- | 95.24%9.85M | ---- | 140.33%5.05M | ---- | -32.10%2.1M |
-Impairment of trade receivables (reversal) | ---- | -175.61%-113K | ---- | -241.38%-41K | ---- | -77.52%29K | ---- | 137.83%129K | ---- | -310.49%-341K |
-Other impairments and provisions | ---- | 12.60%35.11M | ---- | 217.39%31.18M | ---- | 99.78%9.83M | ---- | 101.47%4.92M | ---- | -16.72%2.44M |
Revaluation surplus: | ---- | --247K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | --247K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | 116.77%28K | ---- | 76.64%-167K | ---- | 24.26%-715K | ---- | -863.27%-944K | ---- | 95.84%-98K |
-Loss (gain) on sale of property, machinery and equipment | ---- | 116.77%28K | ---- | 76.64%-167K | ---- | 24.26%-715K | ---- | -863.27%-944K | ---- | 95.84%-98K |
Depreciation and amortization: | ---- | -33.52%10.81M | ---- | 63.61%16.26M | ---- | 15.84%9.94M | ---- | 17.77%8.58M | ---- | 51.82%7.29M |
-Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -4.31%1.78M | ---- | -61.33%1.86M |
Financial expense | ---- | 30.74%7.44M | ---- | 110.63%5.69M | ---- | 33.33%2.7M | ---- | -20.12%2.03M | ---- | 72.80%2.54M |
Special items | ---- | -8.47%108K | ---- | -87.71%118K | ---- | --960K | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | ---- | -19.15%68.92M | ---- | 175.46%85.25M | ---- | -35.06%30.95M | ---- | 56.55%47.66M | ---- | 211.00%30.44M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | 118.69%3.51M | ---- | 45.11%-18.76M | ---- | -12,945.80%-34.18M | ---- | 96.26%-262K | ---- | -287.06%-7M |
Accounts payable increase (decrease) | ---- | -65.67%6.08M | ---- | 4.77%17.7M | ---- | 343.01%16.89M | ---- | -61.55%3.81M | ---- | 495.14%9.92M |
prepayments (increase)decrease | ---- | 228.38%3.36M | ---- | 109.26%1.02M | ---- | -1,050.90%-11.04M | ---- | 119.79%1.16M | ---- | -181.21%-5.87M |
Special items for working capital changes | ---- | -156.70%-4.94M | ---- | -6,306.45%-1.92M | ---- | 101.03%31K | ---- | -621.82%-3.01M | ---- | 73.23%-417K |
Cash from business operations | ---- | -7.64%76.92M | ---- | 3,040.42%83.28M | ---- | -94.63%2.65M | ---- | 82.27%49.36M | ---- | 267.24%27.08M |
Other taxs | ---- | -56.30%-11.95M | ---- | -131.61%-7.64M | ---- | 32.22%-3.3M | ---- | -666.77%-4.87M | ---- | -135.73%-635K |
Interest paid - operating | ---- | -30.74%-7.44M | ---- | -110.63%-5.69M | ---- | -33.33%-2.7M | ---- | 20.12%-2.03M | ---- | -72.80%-2.54M |
Special items of business | 3.48%59.99M | ---- | 487.87%57.98M | ---- | 113.83%9.86M | ---- | -2,724.28%-71.33M | ---- | 118.23%2.72M | ---- |
Net cash from operations | 3.48%59.99M | -17.75%57.54M | 487.87%57.98M | 2,189.43%69.95M | 113.83%9.86M | -107.88%-3.35M | -2,724.28%-71.33M | 77.60%42.46M | 118.23%2.72M | 211.17%23.91M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 1,495.45%2.11M | ---- | 193.33%132K | ---- | -40.00%45K | ---- | -65.60%75K | ---- | 172.50%218K |
Decrease in deposits (increase) | ---- | -489.20%-21.15M | ---- | 118.19%5.44M | ---- | -1,324.55%-29.89M | ---- | 80.70%-2.1M | ---- | -203.66%-10.87M |
Sale of fixed assets | ---- | ---- | ---- | -73.10%202K | ---- | -37.62%751K | ---- | 247.98%1.2M | ---- | -89.55%346K |
Purchase of fixed assets | ---- | 60.06%-6.07M | ---- | -459.52%-15.19M | ---- | -452.95%-2.72M | ---- | 74.21%-491K | ---- | 15.83%-1.9M |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3.99M |
Other items in the investment business | -7.95%-33.35M | ---- | -819.55%-30.9M | ---- | -112.92%-3.36M | ---- | 3,103.00%26.01M | ---- | 97.39%-866K | ---- |
Net cash from investment operations | -7.95%-33.35M | -166.55%-25.11M | -819.55%-30.9M | 70.38%-9.42M | -112.92%-3.36M | -2,327.94%-31.81M | 3,103.00%26.01M | 91.91%-1.31M | 97.39%-866K | -239.50%-16.2M |
Net cash before financing | -1.61%26.64M | -46.43%32.43M | 316.47%27.08M | 272.19%60.53M | 114.35%6.5M | -185.42%-35.15M | -2,547.19%-45.32M | 433.71%41.15M | 103.85%1.85M | -60.04%7.71M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -19.47%527.77M | ---- | 78.26%655.37M | ---- | 67.11%367.64M | ---- | -5.14%220M | ---- | 23.15%231.91M |
Refund | ---- | 22.60%-541.71M | ---- | -126.30%-699.87M | ---- | -38.76%-309.26M | ---- | 1.83%-222.88M | ---- | -14.47%-227.03M |
Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---9M | ---- | ---- | ---- | ---- |
Other items of the financing business | -3.62%13.77M | ---- | 1.20%14.29M | ---- | 235.92%14.12M | ---- | -72.60%4.2M | ---- | -44.24%15.34M | ---- |
Net cash from financing operations | -3.62%13.77M | 52.14%-30.22M | 1.20%14.29M | -265.31%-63.13M | 235.92%14.12M | 454.85%38.19M | -72.60%4.2M | -970.95%-10.76M | -44.24%15.34M | 93.06%-1.01M |
Net Cash | -2.31%40.42M | 184.97%2.21M | 100.59%41.37M | -185.65%-2.6M | 150.16%20.62M | -90.00%3.04M | -339.14%-41.12M | 353.19%30.39M | 183.75%17.19M | 39.48%6.71M |
Begining period cash | 1.18%73.19M | -3.54%70.98M | -1.69%72.34M | 4.31%73.58M | 4.31%73.58M | 75.69%70.55M | 75.69%70.55M | 20.05%40.15M | 20.05%40.15M | 16.79%33.45M |
Cash at the end | -0.09%113.61M | 3.11%73.19M | 20.70%113.71M | -3.54%70.98M | 220.14%94.21M | 4.31%73.58M | -48.69%29.43M | 75.69%70.55M | 343.94%57.35M | 20.05%40.15M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.